See also this year's filing and all EDGAR filings for this company.
PDF Report 0001600620_2023_Aurinia_Pharmaceuticals_Inc.pdf
Logs
Graph
Absolute values for 0001600620, Aurinia Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 442,539,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 6,425,000 |
| 2 | PropertyPlantAndEquipmentNet | 3,650,000 |
| 3 | remainder_Assets | 18,246,000 |
| 4 | LiabilitiesCurrent | 46,107,000 |
| 5 | LiabilitiesNoncurrent | 19,318,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 5,664,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 196,371,000 |
| 9 | ResearchAndDevelopmentExpense | 44,988,000 |
| 10 | remainder_Expenses | 305,000 |
| 11 | remainder_Revenues | 134,030,000 |
| 12 | remainder_NetIncome | 5,118,000 |
| 13 | remainder_ComprehensiveNetIncome | -209,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 470,860,000 |
| 1 | Liabilities | 65,425,000 |
| 2 | Expenses | 247,328,000 |
| 3 | Revenues | 134,030,000 |
| 4 | StockholdersEquity | 405,435,000 |
| 5 | NetIncome | -108,180,000 |
| 6 | ComprehensiveNetIncome | -108,284,500 |
| 7 | BaseVar | 461,485,000 |
| 8 | EconomicCapitalRatio | 2.20 |
Edgar->Model Mapping
Feature Distribution
Change over Time
